• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE; PROSTHESIS, MITRAL VALVE, PERCUTANEOUSLY DELIVERED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE; PROSTHESIS, MITRAL VALVE, PERCUTANEOUSLY DELIVERED Back to Search Results
Model Number 9600TFX29A
Device Problem Insufficient Information (3190)
Patient Problem No Information (3190)
Event Date 05/14/2018
Event Type  Injury  
Manufacturer Narrative
(b)(4).Investigation is ongoing.
 
Event Description
As reported through the implant patient registry (ipr) department, during the tvr procedure in the mitral position, the valve was explanted.
 
Manufacturer Narrative
The explanted valve was not returned to edwards for evaluation.  the location of the valve is unknown at this time.  information pertaining to the reason for explant was not provided.  however, additional information provided by the hospital medical records indicated the patient underwent mvr with a transcatheter tissue valve via sternotomy and remained with open sternum until pod1 after developing significant bleeding that had to be packed.  the patient failed extubation twice and was trached on pod8.  the patient tolerated trach collar during the day and ventilator at night.  the patient was discharged to a long term acute care hospital.     in this case, there was no allegation or indication a device malfunction contributed to this adverse event.  with such limited information, the reason for the valve explant cannot be confirmed.  it is possible that the patient factors and co-morbidities may have contributed to the valve explant.  the ifu and training manuals have been reviewed and no inadequacies have been identified with regards to warnings, contraindications, and the directions/conditions for the successful use of the device. complaint histories for all reported events are reviewed against trending control limits on a monthly basis, and any excursions above the control limits are assessed and documented as part of this monthly review. no corrective or preventative actions are required.
 
Manufacturer Narrative
Corrected data: f10, h6.Reference capa-20-00141.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE
Type of Device
PROSTHESIS, MITRAL VALVE, PERCUTANEOUSLY DELIVERED
Manufacturer (Section D)
EDWARDS LIFESCIENCES
one edwards way
irvine CA 92614
MDR Report Key7584996
MDR Text Key110573218
Report Number2015691-2018-02227
Device Sequence Number1
Product Code NPU
Combination Product (y/n)N
PMA/PMN Number
P140031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup,Followup
Report Date 05/14/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/08/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Expiration Date01/22/2020
Device Model Number9600TFX29A
Was Device Available for Evaluation? No
Date Manufacturer Received07/23/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age66 YR
-
-